116 related articles for article (PubMed ID: 38452634)
1. Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue.
Pandya D; Tomita S; Rhenals MP; Swierczek S; Reid K; Camacho-Vanegas O; Camacho C; Engelman K; Polukort S; RoseFigura J; Chuang L; Andikyan V; Cohen S; Fiedler P; Sieber S; Shih IM; Billaud JN; Sebra R; Reva B; Dottino P; Martignetti JA
Gynecol Oncol; 2024 Jun; 185():194-201. PubMed ID: 38452634
[TBL] [Abstract][Full Text] [Related]
2. Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.
Reid K; Camacho-Vanegas O; Pandya D; Camacho SC; Qiao RF; Kalir T; Padron-Rhenals MM; Beddoe AM; Dottino P; Martignetti JA
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37848227
[TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
Nair N; Camacho-Vanegas O; Rykunov D; Dashkoff M; Camacho SC; Schumacher CA; Irish JC; Harkins TT; Freeman E; Garcia I; Pereira E; Kendall S; Belfer R; Kalir T; Sebra R; Reva B; Dottino P; Martignetti JA
PLoS Med; 2016 Dec; 13(12):e1002206. PubMed ID: 28027320
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic mutations in histologically normal endometrium: the new normal?
Lac V; Nazeran TM; Tessier-Cloutier B; Aguirre-Hernandez R; Albert A; Lum A; Khattra J; Praetorius T; Mason M; Chiu D; Köbel M; Yong PJ; Gilks BC; Anglesio MS; Huntsman DG
J Pathol; 2019 Oct; 249(2):173-181. PubMed ID: 31187483
[TBL] [Abstract][Full Text] [Related]
5. Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors.
Aguilar M; Zhang H; Zhang M; Cantarell B; Sahoo SS; Li HD; Cuevas IC; Lea J; Miller DS; Chen H; Zheng W; Gagan J; Lucas E; Castrillon DH
J Pathol; 2021 May; 254(1):20-30. PubMed ID: 33506979
[TBL] [Abstract][Full Text] [Related]
6. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
Miller EM; Patterson NE; Gressel GM; Karabakhtsian RG; Bejerano-Sagie M; Ravi N; Maslov A; Quispe-Tintaya W; Wang T; Lin J; Smith HO; Goldberg GL; Kuo DYS; Montagna C
BMC Med Genomics; 2020 Nov; 13(1):179. PubMed ID: 33256706
[TBL] [Abstract][Full Text] [Related]
7. Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
Lupini L; Scutiero G; Iannone P; Martinello R; Bassi C; Ravaioli N; Soave I; Bonaccorsi G; Lanza G; Gafà R; Loizzi V; Negrini M; Greco P
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13137. PubMed ID: 31412428
[TBL] [Abstract][Full Text] [Related]
8. The genetic landscape of endometrial clear cell carcinomas.
DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
[TBL] [Abstract][Full Text] [Related]
9. Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy.
Martignetti JA; Pandya D; Nagarsheth N; Chen Y; Camacho O; Tomita S; Brodman M; Ascher-Walsh C; Kolev V; Cohen S; Harkins TT; Schadt EE; Reva B; Sebra R; Dottino P
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30301868
[TBL] [Abstract][Full Text] [Related]
10. Towards less invasive molecular diagnostics for endometrial cancer: massively parallel sequencing of endometrial lavage specimens in women attending for an office hysteroscopy.
Chao A; Wu KY; Lin CY; Lee YS; Huang HJ; Tang YH; Weng CH; Chao AS; Chang TC; Lai CH; Wu RC
J Mol Med (Berl); 2022 Sep; 100(9):1331-1339. PubMed ID: 35953603
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset.
Hong JH; Cho HW; Ouh YT; Lee JK; Chun Y; Gim JA
J Gynecol Oncol; 2022 May; 33(3):e29. PubMed ID: 35128859
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutations in endometrial cancers: relation to PTEN gene defects.
Janiec-Jankowska A; Konopka B; Goluda C; Najmoła U
Int J Gynecol Cancer; 2010 Feb; 20(2):196-202. PubMed ID: 20169661
[TBL] [Abstract][Full Text] [Related]
13. Adenomyosis pathogenesis: insights from next-generation sequencing.
Bulun SE; Yildiz S; Adli M; Wei JJ
Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
[TBL] [Abstract][Full Text] [Related]
14. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings.
Liew PL; Huang RL; Wu TI; Liao CC; Chen CW; Su PH; Wang HC; Weng YC; Lai HC
Clin Epigenetics; 2019 Nov; 11(1):170. PubMed ID: 31779688
[TBL] [Abstract][Full Text] [Related]
15. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
[TBL] [Abstract][Full Text] [Related]
16. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
[TBL] [Abstract][Full Text] [Related]
17. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Tamura R; Mori Y; Yamawaki K; Adachi S; Takahashi T; Kase H; Tanaka K; Yamamoto T; Motoyama T; Inoue I; Enomoto T
Cell Rep; 2018 Aug; 24(7):1777-1789. PubMed ID: 30110635
[TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients.
Bolivar AM; Luthra R; Mehrotra M; Chen W; Barkoh BA; Hu P; Zhang W; Broaddus RR
Mod Pathol; 2019 Mar; 32(3):405-414. PubMed ID: 30315273
[TBL] [Abstract][Full Text] [Related]
19. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.
Catasus L; Gallardo A; Cuatrecasas M; Prat J
Mod Pathol; 2008 Feb; 21(2):131-9. PubMed ID: 18084252
[TBL] [Abstract][Full Text] [Related]
20. Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium.
Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Adachi S; Kase H; Motoyama T; Inoue I; Enomoto T
Hum Reprod; 2019 Oct; 34(10):1899-1905. PubMed ID: 31621846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]